GliaCure has received $5.8 million in Series B funding. The investors were not named. Based in Boston, GliaCure focuses on treating neurological and neuropsychiatric disorders.

from PE Hub Blog http://ift.tt/1sqw1Ps
via IFTTT

Advertisements